Gheorghe-Andrei Dan

Gheorghe-Andrei Dan

Head of Internal Medicine Clinic & Cardiology and Electrophysiology Department

MD PhD FAHA FACC FESC

Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; Academy of Romanian Scientists, Bucharest, Romania

  • OrcidID

Research areas

Atrial Fibrillation

Atherosclerosis and Hyperlipidemia

Biography

Dr Gheorghe-Andrei Dan is Head of Internal Medicine University Clinic, Colentina University Hospital, Bucharest and Head of the Cardiology Department and Diagnostic Cardiovascular Procedures and Arrhythmology Unit – University Hospital Colentina.

Professor – Internal Medicine Department of the University of Medicine and Pharmacy “Carol Davila” Bucharest
Head, Internal Medicine Chair, University of Medicine and Pharmacy “Carol Davila” Bucharest
Leading Research Investigator of the Romanian Academy of Medical Sciences
Chancellor (Scientific Secretary), Faculty of Medicine, University of Medicine “Carol Davila”- Bucharest

Dr Gheorghe-Andrei Dan is on the Editorial Board of European Cardiology Review.

Read more

Media

Broadcast

Anticoagulation

Standards & Guidelines
Edoxaban: ENGAGEing in Individualisation of DOACs

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Broadcast

Heart Failure

Electrophysiology & Arrhythmia
The Role of Landiolol in Clinical Practice

Gheorghe-Andrei Dan, Vasiliki Psallida, Anna Vachulová , et al

Watch time: 1h 7m

Broadcast

Anticoagulation
How to personalize NOAC for special populations and special situations

Gheorghe-Andrei Dan

Watch time: 1h 12m 28s

Articles by Gheorghe-Andrei Dan, Head of Internal Medicine Clinic & Cardiology and Electrophysiology Department

The 2024 European Society of Cardiology Atrial Fibrillation Guidelines: A Moving Goalpost

Gheorghe-Andrei Dan, Antoni Martínez-Rubio,

Published:

Citation: European Cardiology Review 2025;20:e01.

DOI:

https://doi.org/10.15420/ecr.2024.55
What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?

Maki Komiyama, Moritake Iguchi, Hiromichi Wada, et al

Published:

Citation: European Cardiology Review 2024;19:e10.

DOI:

https://doi.org/10.15420/ecr.2023.50
The Predictive Value of NT-proBNP across Glomerular Filtration Rate Subsets in Heart Failure Treated Patients

Diana Ionescu, Caterina Delcea, Adrian Catalin Buzea, et al

Published:

Citation: European Cardiology Review 2023;18:e18.

DOI:

https://doi.org/10.15420/ecr.2023.18.PO1
Perspectives and Future Directions of Anticoagulant Therapy in Coronary Artery Disease Patients

Maki Komiyama, Gheorghe-Andrei Dan, Koji Hasegawa, et al

Published:

Citation: European Cardiology Review 2023;18:e14.

DOI:

https://doi.org/10.15420/ecr.2022.66
2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy

Gheorghe-Andrei Dan,

Published:

Citation: European Cardiology Review 2021;16:e55.

DOI:

https://doi.org/10.15420/ecr.2021.51
Rhythm Control in AF: Have We Reached the Last Frontier?

Gheorghe-Andrei Dan,

Published:

Citation: European Cardiology Review 2019;14(2):77–81

DOI:

https://doi.org/10.15420/ecr.2019.8.1
Cardiovascular Pharmacotherapies Focus: Are low doses of direct-acting oral anticoagulants justified and appropriate in patients with nonvalvular atrial fibrillation?

Antoni Martínez-Rubio, Gheorghe-Andrei Dan,

Citation: European Cardiology Review 2016;11(2):115–7

DOI:

https://doi.org/10.15420/ecr.2016.11.2.ED2
Stroke Prevention in Atrial Fibrillation – The Use of NOACs in Everyday Clinical Practice

Gheorghe-Andrei Dan, Adrian Catalin Buzea,

Citation: European Cardiology Review 2015;10(2):76–8

DOI:

https://doi.org/10.15420/ecr.2015.10.2.76